Latest News from: University of Maryland Medical Center

Filters close
Released: 9-Jul-2013 2:45 PM EDT
Experts Available to Comment on New Guidelines on Aromatase Inhibitors for Breast Cancer Prevention
University of Maryland Medical Center

The American Society of Clinical Oncology (ASCO) is now recommending that physicians discuss use of the aromatase inhibitor exemestane (Aromasin) to prevent breast cancer in at-risk postmenopausal women. Two breast cancer experts at the University of Maryland Greenebaum Cancer Center are available to comment on the new guideline.


Showing results

113 of 13

close
0.50884